2BB score and signals
Vistagen Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 28 | Weak |
| Quality | 80 | Very Strong |
| Risk | 53 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 1998 |
| Employees | 41 |
| 52-week range | $0.20 – $5.14 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-10 | — | -0.3723 | — | $255,000.00 |
| 2026-11-11 | — | -0.3825 | — | $255,000.00 |
| 2026-08-05 | — | -0.3723 | — | $255,000.00 |
| 2026-06-15 | -0.37 | -0.3434 | $465,000.00 | $273,023.00 |
Related companies
2BBBullish & Bearish